Uncertainties about the excess risk of developing a serious form of Covid for cancer patients greatly complicate their management. Difficult for the moment to "conclude for or against a Covid-19 risk for patients with solid tumors" , notes Professor Benjamin Besse, head of the department of oncological medicine at Gustave-Roussy (Villejuif). But if cancer increases the risk associated with Covid, patients and caregivers may be "confronted with difficult decisions (…), such as suspending or continuing anticancer treatments" , or even anticipating decisions relating to the end of life, note the authors of an American study conducted on 928 patients and published in The Lancet .
Read also: Deprogrammed operations gradually resume
In France, adaptations of treatments have been made to limit the exposure of patients, for example by delivering chemotherapy at home by the oral route or by spacing out the sessions, but always "with the requirement that this should not impact on survival, " insists P
This article is for subscribers only. You still have 84% to discover.
Subscribe: € 1 the first month
cancellable at any time
Enter your emailAlready subscribed? Log in
